Provera combined with Vivelle

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 4/5/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/3/2003 56 Female 180 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 50 Female 160 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2000 58 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/25/2002 Female 2/28/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/25/2002 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 6/6/2003 62 Female 3/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 9/14/1999 60 Female 3/28/2006 Lawyer United States
Primary
Secondary
Urinary Tract Infection Other Serious 1/1/1999 63 Female 181 lb 4/20/2006 Physician United States
Primary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 3/7/2002 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 Female 7/17/2006 United States
Primary
Secondary
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Muscle Rupture Hospitalization 8/9/2006 67 Female 150 lb 10/17/2006 Physician United States
Primary
Secondary
Concomitant
Mastectomy Other Serious Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/6/2003 62 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 10/10/2006 United States
Primary
Secondary
Vulvovaginal Mycotic Infection Other Serious 1/1/1995 51 Female 170 lb 2/28/2007 United States
Primary
Secondary
Concomitant
Ventricular Dysfunction Other Serious 2/1/1991 58 Female 3/15/2007 Physician United States
Primary
Secondary
Venous Insufficiency Other Serious 11/1/1999 56 Female 3/15/2007 United States
Primary
Secondary
Venous Insufficiency Other Serious 8/15/1999 54 Female 118 lb 3/17/2007
Primary
Secondary
Uterine Leiomyoma Other Serious 1/1/1995 51 Female 3/27/2007 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 198 lb 3/28/2007 United States
Primary
Secondary
Concomitant
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Mastectomy Other Serious 62 Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Operation Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/3/2003 56 Female 178 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/14/1999 60 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Ventricular Extrasystoles Other Serious 4/1/2000 59 Female 5/10/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 66 Female 125 lb 7/9/2007 United States
Primary
Secondary
Uterine Prolapse Other Serious 1/1/1994 56 Female 7/18/2007 United States
Primary
Secondary
Wound Debridement Other Serious 1/1/1999 62 Female 150 lb 8/3/2007 United States
Primary
Secondary
Concomitant
Tubal Ligation Other Serious 1/1/1993 55 Female 155 lb 8/3/2007 Lawyer United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 11/29/1996 51 Female 138 lb 8/23/2007 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 8/1/2002 54 Female 145 lb 10/16/2007 United States
Primary
Secondary
Concomitant
Uterine Disorder Other Serious 1/1/1997 56 Female 190 lb 10/29/2007 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/21/1989 51 Female 11/3/2007 United States
Primary
Secondary
Polypectomy Other Serious 8/15/1999 54 Female 118 lb 11/3/2007
Primary
Secondary
Ultrasound Breast Abnormal Other Serious 1/1/2000 11/3/2007 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 190 lb 11/3/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1993 59 Female 165 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Ultrasound Doppler Abnormal Hospitalization 50 Female 179 lb 9/17/2007 Lawyer United States
Primary
Secondary
Vein Disorder Other Serious 11/1/1999 56 Female 12/4/2007 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 57 Female 139 lb 1/10/2008 Physician United States
Primary
Secondary
Concomitant
Uterine Prolapse Other Serious 1/1/1994 56 Female 1/10/2008 United States
Primary
Secondary
Simple Mastectomy Other Serious 1/1/2000 58 Female 130 lb 11/5/2007 Physician United States
Primary
Secondary
Concomitant
Wound Closure Other Serious 1/1/1999 62 Female 150 lb 1/23/2008 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/1997 56 Female 190 lb 1/23/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2000 58 Female 120 lb 12/18/2007 United States
Primary
Secondary
Concomitant
Surgery Other Serious 5/3/1998 52 Female 155 lb 3/27/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2003 Female 4/1/2008 Lawyer United Kingdom
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 56 Female 157 lb 4/8/2008 United States
Primary
Secondary
Concomitant
Wound Closure Other Serious 1/1/1999 62 Female 150 lb 4/22/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 5/22/2008 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 Female 190 lb 6/4/2008 United States
Primary
Secondary
Surgery Other Serious 5/3/1998 Female 155 lb 6/13/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 6/13/2008 Consumer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 6/18/2008 United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 Female 157 lb 6/19/2008 United States
Primary
Secondary
Concomitant
Squamous Cell Carcinoma Of Skin Other Serious 1/1/1993 Female 155 lb 7/10/2008 Lawyer United States
Primary
Secondary
Concomitant
Interacting
Wound Closure Other Serious 1/1/1998 Female 150 lb 7/15/2008 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 7/14/1988 Female 190 lb 7/22/2008 United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 7/31/2008 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 7/30/2008 United States
Primary
Secondary
Nipple Disorder Other Serious 8/1/2002 Female 146 lb 8/13/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 48 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 57 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/6/2003 60 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 58 10/9/2008 United States
Primary
Secondary
Vein Disorder Other Serious 8/15/1999 Female 118 lb 1/14/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 9/14/2007 Female 1/15/2009 Consumer United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 1/14/2009 United States
Primary
Secondary

Drug Data